We are delighted to announce that Miro Venturi is our new Corporate CEO. Welcome aboard Miro!
Miro has received a combined humanistic and scientific education by first attending the Liceo Linguistico in Faenza and later studying chemistry and biology at the University of Bologna, where he received his first degree in Biology and Biochemistry.
After that, Miro earned his Doctorate (PhD) in Biophysics at the Max-Planck Institute of Frankfurt/Main, Germany, (in the Team of Nobel laureate Prof. Dr. Hartmut Michel) and later a postdoctoral specialization in Molecular Medicine at the National Institutes of Health in Bethesda, Maryland, under the US Government sponsorship.
His scientific work lead to several patents and has been published in more than 60 peer-reviewed international articles and internationally cited across the academic and industrial communities.
Miro joined the pharmaceutical industry in 2000, driven by the desire to apply science for the benefits of patients: he has built translational sciences and patients’ focused drug development organizations across a range of therapeutic areas, always with an emphasis in helping to globally scale biomarker-driven drug development, and realize the promise of precision medicine and personalized therapies.
This work has helped Roche Pharmaceuticals to significantly streamline, accelerate and improve drug development and pipeline activity, leading to the successful market launch of numerous blockbuster drugs in recent years. At Roche, Miro has been Global Project Leader, then Global Head of Oncology Personalized Healthcare to later becoming a senior executive within the Roche Divisional Strategy & Business Development organization, where his Team was responsible for the assessment of licensing, mergers and acquisition opportunities and deals supporting the precision medicine strategy of the company worldwide.
Miro and his Team’s activities have also been instrumental for the Roche Diagnostics Division to embrace the digital revolution and launch products (such as the NAVIFy platform and associated SaaS products) to expand its customer base to physicians and execute upon a new diagnostic value-based business model.
Miro’s most recent role within the Roche Group has been as Chief Business Officer and Member of the Executive Committee for Foundation Medicine, a company leader in the field of next generation data-driven diagnostics for cancer patients.
Miro is a native Italian and speaks English, German and French.
toYOU, the person at the centre
Signed agreements between employees and the company which enable employees to give life and substance to essential life projects: in the areas of training, family care and socio-cultural paths.
It is with pride that Sintetica, the oldest pharmaceutical company in Canton of Ticino, presents toYOU, its most recent and innovative action in the context of the human centric organisation.
Sintetica believes that important life projects undertaken by its employees should be supported by facilitating their implementation as far as possible. From this vision, which rewrites the concept of benefits, the great construction site "toYOU: the project pacts in Synthetica" was born.
These three areas were as a holistic declination of the "manocentric" vision, an entrepreneurial and humanistic philosophy that constitutes the profound essence of this highly innovative company.
Global Pharmaceutical CEO of the year 2020
From the United States comes an important recognition for Sintetica. The magazine Corporate America Today has awarded our CEO Augusto Mitidieri as Global Pharmaceutical CEO of the year 2020.
The Humancentric organizational model and its ability to foster innovation have impressed the panel of experts. It has also been underlined how Sintetica met the swiss and the international demand of its Intensive Care Unit‘s drugs at global level during this CV19 emergency. Once again, Sintetica nds success at international level for its true excellence: its people.
Congratulations to our CEO, heartfelt and aectionate. To all of you a big and sincere thanks for what you do every day.
Congratulations Augusto Mitidieri, Corporate CEO
Corporate American Today awards Augusto Mitidieri, Corporate CEO, Global Pharmaceutical CEO of the Year 2020
Augusto Mitidieri - Most Influential CEO Europe 2019 for Humancentric Driven Innovation -
An internationally recognised, concrete example of scientific innovation and innovative corporate philosophy. The path undertaken by Sintetica (the oldest pharmaceutical company in Ticino), guided by its CEO Augusto Mitidieri, is not only littered with success on the global markets but is also making a name for itself with its innovative strength and ability. It is no coincidence that “Leadership by Innovation” is one of its distinguishing features.
Recently a new award, presented by CV Magazine to Augusto Mitidieri as the “Most Influential CEO Europe 2019 for Humancentric Driven Innovation”, has further confirmed the high quality of this story of courage and success.
In the interview conducted by the magazine (www.cv-magazine.com/2019-humancentric-driven-innovation), Sintetica's CEO focuses on some of the cornerstones of this revolution in growth and development methods, of course, but also on the development of a different kind of corporate philosophy.
This award is a source of great satisfaction for this modern company, specialised in the production of top quality drugs for pain management and local anaesthesia.
Le Fonti Awards 2019
Augusto Mitidieri - CEO of the Year for Sustainability in pharma industry
An innovative strategy and corporate philosophy pursued with perseverance and determination have earned Sintetica’s CEO, Augusto Mitidieri, an important new award. Le Fonti Awards have, in fact, named him "CEO of the Year for Sustainability in pharma industry" for the third year running.
Augusto Mitidieri was presented with the coveted award during a ceremony held in Milan. The official motivation behind the award, also released publically, is as follows: " For confirming himself for the third year running as the most far-sighted CEO in the pharmaceutical sector in terms of sustainability: his innovative approach to care, human resource development and a focus on the environment mean he is the one setting the benchmark at international level.
Business Worldwide CEO Awards 2019
Augusto Mitidieri is the "Most Innovative Pharmaceutical CEO – Europe”
A new prestigious award has been assigned to the CEO of Sintetica Augusto Mitidieri, named “Most Innovative Pharmaceutical CEO – Europe” for 2019 by Business Worldwide Magazine (BWM).
Augusto Mitidieri, as the BWM press release reports, won the title outright “impressing the judges with his collaborative management strategy”.
The goal of the Business Worldwide CEO Awards 2019 is to identify and celebrate exceptional leaders from all parts of the world in various sectors.
Unlike other titles, generally focused on the company structures, the focus of the Business Worldwide CEO Awards is on the individual, their leadership abilities and the unique qualities that set them apart from the others.
By illustrating their talent and management skills, the intention is to encourage and motivate other business leaders to achieve similar goals.
Commenting on the concept of the human-centric vision on which he decided to mould Sintetica, Augusto Mitidieri told BWM:
“Passion is the real driving force behind Sintetica. And it is important for our people to be aware that they can make a dierence and help change things for the better, knowing that every action has an impact on society.
We encourage people to smile.
And a real smile is contagious. It identies Sintetica and represents the real essence of the concept of a great place to work”.
Sintetica from Westminster to the World
Sintetica has been chosen to feature in a commemorative album marking the 70th anniversary of the Commonwealth.
"I would like to share with you an honour bestowed upon our company because of the unique human-centred way Sintetica is run, which is seen as a global model for sustainability and is the foundation of our future as a successful business.
Sintetica is one of only two pharmaceutical companies, to have been chosen to feature in a commemorative album marking the 70th anniversary of the Commonwealth.
It is one of the most ambitious, authoritative and well-researched academic projects in British history.
I, personally, was interviewed by His Royal Highness Prince Charles’ biographer and royal correspondent, Robert Jobson, who asked me about the work of Sintetica and why respect, innovation and diversity are so important.
HRH Prince Charles will become head of the Commonwealth when his mother, Her Majesty, Queen Elizabeth II stands down. Prince Charles has long been a supporter of sustainability and the environment. He worked with Cambridge University to set up the Business and Sustainability Programme for business leaders and senior executives who need to make the right long-term decisions to ensure their organizations grow sustainably and profitably; which is why Prince Charles worked with the History of Parliament Trust to select the organizations chosen to be a part of this significant project in British history.
The commemorative album “The Commonwealth at 70: From Westminster to the World” includes photographs, stories and thought-provoking debate on all aspects of the states that make up the Commonwealth. It brings together best practice and offers an insight into the major Commonwealth institutions, organizations and initiatives. It shows how countries can work together for the common interests of its peoples. Business can learn from this understanding and co-operation.
I am proud of the work we do and thrilled to have received such a recognition at Westminster Abbey in London, which has one thousand years of heritage and seen many royal occasions.
Thank you for your precious support holding Sintetica up to the world as a model for success and sustainability."
Augusto Mitidieri Corporate CEO of Sintetica Awarded Best Manager of the Year
Augusto Mitidieri, CEO, has been awarded Best Manager of the Year for high achievements and professionalism in the company management.
Awarded by The Socrates Committee of Oxford this award recognises exceptional human-centric leadership and the global success of Sintetica.
This award was presented at the Socrates Award Ceremony of the Achievements Forum 2019, Institute of Directors, London.
Additionally, the Europe Business Assembly (EBA) Corporation of Social Partnership awarded Sintetica SA, Switzerland, Best Enterprise Award.
“Recognition of the exceptional global leadership of our CEO, Augusto Mitidieri, not only distinguishes an inspirational leader, it provides all of Sintetica with a huge feel good factor. Sintetica is a great place to work and feeling good about the work that we all do is in the heart of all of us.”
Speaking from London,
Most Influential CEO of the Year 2018 – Europe
The CEO of Sintetica Mendrisio has been presented with this prestigious award from CV-Magazine. “Most Influential CEO of the Year 2018 – Europe”.
This is the new and prestigious award which Corporate Vision Magazine has presented to Augusto Mitidieri, CEO of Sintetica, the oldest pharmaceutical company in the Canton of Ticino.
In presenting this award, which marks an additional milestone in the international recognition of the corporate strategy which Sintetica has been following under the leadership of its CEO, CV-Magazine focuses in particular on the elements that make up the “human-centric” philosophy which Mitidieri has brought to the operative and functional heart of the company.
To this end, the conclusion to the article/interview which CV-Magazine published in its latest issue is of note (www.cv-magazine.com/issues/issue-3-2019/6/):
“Augusto and the team at Sintetica will continue to deliver their exceptional services which has seen them take great strides within the industry, leading the way for others to follow. Additionally, Augusto will continue to direct his team towards success with his award-winning leadership skills, especially following his recent recognition in Corporate Vision’s 2018 Leadership Elite Awards where he was righteously awarded to accolade Most Influential CEO of the Year 2018 – Europe”.
CV Magazine - Small Business Awards 2018
Pharmaceutical CEO of the year 2018: Augusto Mitidieri
EUROPEAN CEO AWARDS 2018
THE CEO OF SINTETICA